INTRODUCTION
============

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by the novel bunyavirus, called SFTS virus, which was first reported in China in 2011[@B1] and Korea and Japan in 2013.[@B2][@B3] The virus is transmitted by ticks such as *Haemaphysalis longicornis*.[@B1] The clinical manifestations of SFTS are nonspecific and include fever, myalgia, vomiting, and diarrhea. In critically ill patients, multi-organ failure may occur.[@B4] There is no effective antiviral therapy, and the mortality ranges from 6.3% to 30%.[@B5][@B6] Because SFTS is a disease with a rapidly progressive deterioration and high mortality rate, early diagnosis is important for survival of patients and preventing transmission of infection.[@B6][@B7]

Although the number of SFTS cases has increased steadily, with 259 patients with SFTS in 2018, other endemic zoonoses, such as scrub typhus (6,682 patients), hemorrhagic fever with renal syndrome (HFRS) (433), and leptospirosis (118) were more prevalent in Korea.[@B8] Moreover, early clinical manifestations of SFTS are similar to those of other endemic zoonoses; therefore, SFTS needs to be differentiated from these diseases. Although the quantitative real-time reverse-transcriptase polymerase chain reaction (RT-PCR) assay is a reliable method for early diagnosis of SFTS,[@B9] this test could not be performed by most primary care providers at local clinics.

Therefore, we aimed to derive a clinical prediction scoring system with initial symptoms and basic laboratory blood tests that could be useful for primary care providers to differentiate SFTS from other endemic zoonoses. We also evaluated the predictability of the score, reassessed 2 days after admission in patients with low probability of SFTS.

METHODS
=======

Patients and data collection
----------------------------

Patients aged 18 years or older diagnosed with endemic zoonoses during the 3-year period from January 2015 to December 2017 were enrolled from 4 university hospitals in Korea: Seoul National University Bundang Hospital (1,300 beds), Boramae Medical Center (800 beds), Seoul National University Hospital (1,700 beds), and Kangwon National University Hospital (600 beds). Endemic zoonoses included SFTS, scrub typhus, HFRS, leptospirosis, Q fever, and human granulocytic anaplasmosis (HGA). All patients with a diagnosis code and/or confirmatory test results of endemic zoonoses were screened.

SFTS was confirmed by detecting the M segment gene of the viral ribonucleic acid (RNA) with RT-PCR as described in a previous study.[@B10] Scrub typhus was diagnosed by a single titer ≥ 1:160[@B11] or a ≥ 4-fold rise in indirect immunofluorescent assay (IFA) titer in paired serum samples. HFRS was diagnosed by a single titer ≥ 1:80, ≥ 4-fold rise in IFA titer in paired serum samples, or positive RT-PCR test. Considering the incidence and importance of these endemic zoonoses in Korea, we included only the patients with all three of the above results in this study. Leptospirosis was diagnosed by ≥ 4-fold rise in IFA titer in paired serum samples or an antibody titer ≥ 1:800 in one serum sample by the microscopic agglutination test. Q fever was diagnosed by ≥ 4-fold rise an antiphase II antigen immunoglobulin G titer in paired serum samples. HGA was diagnosed by ≥ 4-fold rise in IFA titer in paired serum samples or positive PCR test. We excluded patients with bacteremia or co-infections between endemic zoonoses.

We retrospectively reviewed the demographic and clinical data of the patients, including age, gender, occupation, comorbidities, presence of symptoms, and laboratory findings, to analyze the differentiating factors between SFTS and other endemic zoonoses.

Neurologic symptoms included altered mentality, for which Glasgow coma scale score is \< 15, and tremor, motor weakness, and dysarthria, which were based on the information in the physician or nurse\'s medical records. Diarrhea was defined as three or more unformed stools per day, and we also considered that diarrhea was present when the attending physician described diarrhea symptoms in the patient\'s medical record. Leukopenia was defined as white blood cell count \< 4,000/mm^3^. Thrombocytopenia was defined as blood platelet count \< 150 × 10^3^/mm^3^. Normal C-reactive protein (CRP) was defined as \< 0.5 mg/dL.

Statistical analysis
--------------------

Categorical variables were compared using χ^2^ or Fisher\'s exact tests, and continuous variables were compared using *t*-test or Mann-Whitney U test. Multivariate logistic regression analysis was performed using the significant differentiating factors (*P* \< 0.05) between SFTS and other endemic zoonoses in univariate analysis and adjusted for the duration from the onset of illness to the initial presentation. We excluded some variables that could be influenced by recall bias or had insufficient description (e.g., insect bite wound) from the multivariate analysis. For possible overlapping variables (e.g., anemia and bleeding), we constructed separate models. Variables without all patients\' data were excluded from multivariate regression model. The prediction score for SFTS was built based on the final multivariate regression model. The receiver operating characteristic (ROC) curve was constructed for scoring model. Statistical analyses were performed using SPSS for Windows (version 18 software package; SPSS, Inc., Chicago, IL, USA).

Ethics statement
----------------

This study was approved by the Institutional Review Board (IRB) of Seoul National University Bundang Hospital (B-1801/445-112), which waived the need to obtain informed consent from the patients. All the other institutions participating in this study also obtained approvals from their IRBs. All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.

RESULTS
=======

A total of 202 patients were diagnosed with endemic zoonoses clinically and/or by laboratory tests during the 3-year period including 49 patients with SFTS, 132 with scrub typhus, 18 with HFRS, 2 with Q fever, and 1 with leptospirosis. Of these, 118 patients (without the test results for the following three, SFTS, scrub typhus, and HFRS, or with other bacterial infection) were excluded. Finally, 84 patients including 35 with SFTS and 49 with other endemic zoonoses (40 scrub typhus and 9 HFRS) were enrolled in this study ([Supplementary Fig. 1](#S3){ref-type="supplementary-material"}). None of the patients clinically diagnosed with leptospirosis, Q fever, or HGA met the enrollment criteria. Patients\' demographic and clinical characteristics are described in [Table 1](#T1){ref-type="table"}. At the initial presentation, diarrhea and neurologic symptoms were more common in SFTS patients than in other endemic zoonoses patients. In the laboratory findings, the elevation of aspartate aminotransferase (AST), creatinine kinase, and ferritin were also more common in SFTS patients than in others. White blood cell (WBC), CRP, and procalcitonin were rarely elevated in SFTS. In addition, on comparing the three diseases, younger men were more common in the HFRS group, and no rash was observed. Diarrhea, neurologic symptoms, and normal CRP were more common in the SFTS group ([Supplementary Table 1](#S1){ref-type="supplementary-material"}).

###### Comparison of patients\' baseline clinical characteristics and laboratory results between SFTS and other endemic zoonoses
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  Variables                                         SFTS (n = 35)             Other endemic zoonoses^a^ (n = 49)   *P* value                    
  ------------------------------------------------- ------------------------- ------------------------------------ ---------------- ----------- ----------
  Age, yr                                           64.5 ± 11.0               62.5 ± 19.7                          0.640                        
  Gender, men                                       23 (65.7)                 25 (51.0)                            0.180                        
  Occupation                                                                                                                                    
                                                    Farmers                   14 (40.0)                            20 (40.8)        0.940       
  Underlying disease                                                                                                                            
                                                    Diabetes                  7 (20.0)                             6 (12.2)         0.333       
                                                    Cerebrovascular disease   1 (2.9)                              2 (4.1)          1.000       
                                                    Chronic kidney disease    0 (0)                                1 (2.0)          1.000       
                                                    Chronic lung disease      0 (0)                                2 (4.1)          0.508       
                                                    Chronic liver disease     0 (0)                                1 (2.0)          1.000       
                                                    Solid tumor               0 (0)                                3 (6.1)          0.262       
  Onset to admission, day                           5.7 ± 2.5                 5.7 ± 3.2                            0.996                        
  Clinical characteristics                                                                                                                      
                                                    Fever                     30 (85.7)                            41 (85.4)        0.970       
                                                    Rash                      7 (20.0)                             15 (30.6)        0.275       
                                                    Insect bite wound         11 (31.4)                            26 (53.1)        0.049       
                                                    Lymphadenopathy           5 (14.3)                             1 (2.0)          0.078       
                                                    Myalgia                   21 (60.0)                            33 (67.3)        0.488       
                                                    Nausea/vomiting           14 (40.0)                            13 (26.5)        0.193       
                                                    Diarrhea                  19 (54.3)                            6 (12.2)         \< 0.001    
                                                    Abdominal pain            13 (37.1)                            13 (26.5)        0.300       
                                                    Bleeding                  9 (25.7)                             5 (10.2)         0.060       
                                                    Cough/sputum/dyspnea      10 (28.6)                            20 (40.8)        0.248       
                                                    Headache                  13 (37.1)                            12 (24.5)        0.211       
                                                    Neurologic symptoms       21 (60.0)                            8 (16.3)         \< 0.001    
  Leukopenia, WBC \< 4,000/mm^3^                    28 (80.0)                 5 (10.2)                             \< 0.001                     
  Leukocytosis, WBC \> 10,000/mm^3^                 1 (2.9)                   17 (34.7)                            \< 0.001                     
                                                    WBC, /mm^3^               3,095 ± 2,101                        10,056 ± 7,867   \< 0.001    
                                                                              Neutrophil, %                        54 ± 19          71 ± 16     \< 0.001
                                                                              Lymphocyte, %                        32 ± 15          18 ± 11     \< 0.001
                                                                              Monocyte, %                          8.5 ± 8.5        7.4 ± 6.7   0.676
  Anemia, hemoglobin \< 11 g/dL                     0 (0)                     6 (12.2)                             0.038                        
                                                    Hemoglobin, g/dL          14.2 ± 1.5                           13.3 ± 2.7       0.007       
  Thrombocytopenia, platelet \< 150 × 10^3^/mm^3^   33 (94.3)                 40 (81.6)                            0.111                        
                                                    Platelet, × 10^3^/mm^3^   78 ± 40                              97 ± 64          0.276       
  PT, INR                                           1.01 ± 0.12               1.10 ± 0.18                          0.004                        
  aPTT, sec                                         57 ± 21                   44 ± 18                              \< 0.001                     
  Fibrinogen, mg/dL^b^                              261 ± 52                  345 ± 126                            0.004                        
  Abnormal LFT, AST or ALT \> 40 IU/L               31 (88.6)                 47 (95.9)                            0.229                        
                                                    AST, IU/L                 530 ± 899                            147 ± 175        0.014       
                                                    ALT, IU/L                 161 ± 167                            94 ± 102         0.142       
                                                    ALP, IU/L                 119 ± 106                            128 ± 71         0.013       
                                                    Total bilirubin, mg/dL    0.5 ± 0.2                            1.0 ± 0.8        \< 0.001    
  BUN, mg/dL                                        22.3 ± 18.3               24.5 ± 18.4                          0.295                        
  Creatinine, mg/dL                                 1.0 ± 0.5                 1.2 ± 1.2                            0.967                        
  ESR, mm/hr^b^                                     10 ± 11                   28 ± 25                              0.267                        
  Normal CRP, \< 0.5 mg/dL                          17 (48.6)                 2 (4.1)                              \< 0.001                     
                                                    CRP, mg/dL                1.40 ± 1.77                          11.13 ± 7.75     \< 0.001    
  LDH, IU/L^b^                                      1,297 ± 1,229             833 ± 426                            0.205                        
  Creatine kinase, IU/L^b^                          1,249 ± 1,502             187 ± 354                            \< 0.001                     
  Ferritin, ng/mL^b^                                14,942 ± 26,706           324 ± 37                             0.026                        
  Procalcitonin, ng/mL^b^                           0.16 ± 0.05               2.97 ± 5.26                          0.001                        

Data are presented as mean ± standard deviation or number (%).

SFTS = severe fever with thrombocytopenia syndrome, WBC = white blood cell, PT = prothrombin time, INR = international normalized ratio, aPTT = activated partial thromboplastin time, LFT = liver function test, AST = aspartate aminotransferase, ALT = alanine aminotransferase, IU =international unit, ALP = alkaline phosphatase, BUN =blood urea nitrogen, ESR =erythrocyte sedimentation rate, CRP = C-reactive protein, LDH = lactate dehydrogenase.

^a^Number of patients with other endemic zoonoses: scrub typhus 40, hemorrhagic fever with renal syndrome 9; ^b^Number of patients with the biomarkers results: Fibrinogen (SFTS 19, other endemic zoonoses 20), ESR (SFTS 2, other endemic zoonoses 4), LDH (SFTS 28, other endemic zoonoses 32), Creatinine kinase (SFTS 34, other endemic zoonoses 42), Ferritin (SFTS 11, other endemic zoonoses 2), and Procalcitonin (SFTS 4, other endemic zoonoses 11).

In the multivariate logistic regression analysis, neurologic symptoms, diarrhea, leukopenia, and normal CRP were significantly associated with SFTS rather than with other endemic zoonoses ([Table 2](#T2){ref-type="table"}).

###### Results of univariate and multivariate logistic regression analyses of the clinical and laboratory factors associated with SFTS
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  Variables      OR                        95% CI            *P* value                                       
  -------------- ------------------------- ----------------- ----------------- -------------- -------------- ----------
  Univariate                                                                                                 
                 Age                       1.007             0.981--1.035      0.590                         
                 Gender, men               0.543             0.222--1.330      0.182                         
                 Farmers                   1.034             0.427--2.505      0.940                         
                 Diabetes                  1.792             0.545--5.888      0.337                         
                 Cerebrovascular disease   0.691             0.060--7.935      0.767                         
                 Onset of illness          0.998             0.859--1.159      0.979                         
                 Fever                     1.024             0.296--3.542      0.970                         
                 Rash                      0.567             0.203--1.583      0.278                         
                 Insect bite wound         0.405             0.164--1.005      0.051                         
                 Lymphadenopathy           8.000             0.891--71.837     0.063                         
                 Myalgia                   0.727             0.295--1.793      0.489                         
                 Nausea/vomiting           1.846             0.731--4.666      0.195                         
                 Diarrhea                  8.510             2.883--25.124     \< 0.001                      
                 Abdominal pain            1.636             0.643--4.164      0.301                         
                 Bleeding                  3.046             0.921--10.072     0.068                         
                 Cough/sputum/dyspnea      0.580             0.229--1.468      0.250                         
                 Headache                  1.822             0.708--4.690      0.214                         
                 Neurologic symptoms       7.687             2.785--21.223     \< 0.001                      
                 Leukopenia                35.200            10.170--121.832   \< 0.001                      
                 Leukocytosis              0.055             0.007--0.440      0.006                         
                                           WBC               0.999             0.999--1.000   \< 0.001       
                                                             Neutrophil        0.947          0.920--0.976   \< 0.001
                                                             Lymphocyte        1.079          1.037--1.123   \< 0.001
                                                             Monocyte          1.019          0.962--1.079   0.529
                 Hemoglobin                1.195             0.974--1.465      0.088                         
                 Thrombocytopenia          3.712             0.750--18.388     0.108                         
                                           Platelet          0.994             0.985--1.002   0.132          
                 PT                        0.006             0--0.382          0.015                         
                 aPTT                      1.038             1.009--1.069      0.011                         
                 Fibrinogen                0.991             0.983--0.999      0.020                         
                 Abnormal LFT              0.330             0.057--1.911      0.216                         
                                           AST               1.003             1.001--1.005   0.013          
                                           ALT               1.004             1.000--1.008   0.041          
                                           ALP               0.999             0.994--1.004   0.667          
                                           Total bilirubin   0.038             0.006--0.234   \< 0.001       
                 BUN                       0.993             0.969--1.018      0.588                         
                 Creatinine                0.798             0.479--1.331      0.387                         
                 ESR                       0.923             0.775--1.099      0.367                         
                 Normal CRP                22.194            4.652--105.899    \< 0.001                      
                                           CRP               0.572             0.433--0.756   \< 0.001       
                 LDH                       1.001             1.000--1.002      0.077                         
                 Creatine kinase           1.002             1.001--1.003      0.003                         
                 Ferritin                  1.177             0.010--141.933    0.947                         
  Multivariate                                                                                               
                 Neurologic symptoms       12.915            2.173--76.747     0.005                         
                 Diarrhea                  10.306            1.588--66.895     0.015                         
                 Bleeding                  1.848             0.205--16.636     0.584                         
                 Leukopenia                19.400            3.290--114.408    0.001                         
                 Normal CRP                24.739            1.812--337.742    0.016                         
                 Onset of illness          0.855             0.631--1.160      0.315                         

SFTS = severe fever with thrombocytopenia syndrome, OR = odds ratio, CI = confidence interval, WBC = white blood cell, PT = prothrombin time, aPTT = activated partial thromboplastin time, LFT = liver function test, AST = aspartate aminotransferase, ALT = alanine aminotransferase, ALP = alkaline phosphatase, BUN = blood urea nitrogen, ESR = erythrocyte sedimentation rate, CRP = C-reactive protein, LDH = lactate dehydrogenase.

A prediction score for SFTS in comparison with other endemic zoonoses was generated using the combination of those 4 parameters (using 1 point each for neurologic symptoms, diarrhea, leukopenia, and normal CRP) and the total sum ranged from 0 to 4. On the ROC curve obtained for the model, the optimal cut-off was ≥ 2 points. A score of ≥ 2 had 82.9% sensitivity (95% confidence interval \[CI\], 71.7%--87.5%) and 95.9% specificity (95% CI, 88.0%--99.2%) for SFTS with ROC area under the curve of 0.950 (95% CI, 0.903--0.997) ([Table 3](#T3){ref-type="table"} and [Fig. 1](#F1){ref-type="fig"}).

###### Diagnostic performance of the SFTS prediction score system^a^
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  Cut-off   Sensitivity (95% CI)   Specificity (95% CI)   PPV (95% CI)           NPV (95% CI)           LR+ (95% CI)              LR− (95% CI)
  --------- ---------------------- ---------------------- ---------------------- ---------------------- ------------------------- ----------------------
  1         0.971 (0.857--0.999)   0.612 (0.531--0.632)   0.642 (0.566--0.659)   0.968 (0.839--0.998)   2.505 (1.828--2.710)      0.047 (0.002--0.268)
  2         0.829 (0.717--0.875)   0.959 (0.880--0.992)   0.935 (0.810--0.988)   0.887 (0.813--0.918)   20.300 (5.966--116.491)   0.179 (0.126--0.321)
  3         0.429 (0.330--0.429)   1.000 (0.930--1.000)   1.000 (0.770--1.000)   0.710 (0.660--0.710)   NA                        0.571 (0.571--0.721)
  4         0.200 (0.116--0.200)   1.000 (0.940--1.000)   1.000 (0.579--1.000)   0.636 (0.598--0.636)   NA                        0.800 (0.800--0.941)

SFTS = severe fever with thrombocytopenia syndrome, CI = confidence interval, PPV = positive predictive value, NPV = negative predictive value, LR+ = positive likelihood ratio, LR− = negative likelihood ratio, NA = not available.

^a^Prediction score system = (1 × neurologic symptoms) + (1 × diarrhea) + (1 ×leukopenia) + (1 × normal CRP).

![ROC curve of the clinical prediction score for SFTS in patients with endemic zoonoses.\
ROC = receiver operating characteristic, SFTS = severe fever with thrombocytopenia syndrome.](jkms-35-e77-g001){#F1}

When we applied this prediction score according to the cut-off ≥ 2, 29 patients had SFTS and 2 patients had other endemic zoonoses ([Supplementary Fig. 1](#S3){ref-type="supplementary-material"}). Among 53 patients with a prediction score of 0 or 1, 27 patients had clinical data on the 4 parameters 2 days after admission. Of the 22 patients with other endemic zoonoses and a score of 0 or 1, only 4 patients had diarrhea, and none had neurologic symptoms, leukopenia, or normal CRP. A score ≥ 2 had 100.0% positive predictive value (95% CI, 55.0%--100.0%) ([Supplementary Table 2](#S2){ref-type="supplementary-material"}).

DISCUSSION
==========

The present study identified the predictors of SFTS and suggested a clinical scoring system to distinguish SFTS patients from patients with other endemic zoonoses. This system consists of easily applicable clinical parameters, including neurologic symptoms, diarrhea, leukopenia, and normal CRP. This scoring system would be useful for early differentiation of SFTS from other endemic zoonoses.

SFTS is already an endemic disease in Korea. Han et al.[@B12] reported an SFTS virus seroprevalence of 4.1% among residents of rural areas in Korea. Most SFTS cases occur from April to November in Korea.[@B6] Scrub typhus and HFRS are common zoonotic diseases in Korea, and are prevalent during autumn. Most of the scrub typhus cases occur between October and November.[@B13] Similarly, HFRS predominantly occurs during the last quarter of the calendar year.[@B14] It is important to differentiate between SFTS and these endemic zoonoses because of their overlapping epidemic seasons.

Recently, two studies addressing the differentiation of SFTS from scrub typhus were published.[@B15][@B16] In particular, Park et al.[@B16] proposed a prediction scoring tool to differentiate SFTS from eschar- or skin rash- negative scrub typhus, as it involves diagnostic uncertainty. Furthermore, there has been a report of the usefulness of ferritin as a diagnostic marker to distinguish between SFTS and bacteremia with thrombocytopenia.[@B17] However, there was no previous study that has differentiated SFTS from other endemic zoonoses in Korea.

Our clinical score system to predict SFTS used four variables (neurologic symptoms, diarrhea, leukopenia, and normal CRP), which could easily be available in the primary care settings. Although no specific therapy is available for SFTS, and symptomatic and supportive care is the mainstay of treatment,[@B5] several rescue therapies such as ribavirin and plasma exchange[@B18] or intravenous immunoglobulin and corticosteroid[@B19] may be effective in treating rapidly progressive SFTS. Our clinical score system could help clinicians to stratify the patients so that they can decide on whether to try these therapies or make an early referral, particularly in primary care settings.[@B16]

However, SFTS can spread via human-to-human transmission through blood contact, unlike other endemic zoonoses including scrub typhus.[@B20] Kim et al.[@B21] reported in Korea that of the 27 healthcare workers who had contact with a severely ill SFTS patient, the 4 who were involved in cardiopulmonary resuscitation were diagnosed with SFTS via seroconversion. Using our clinical score system could facilitate early referral of patients suspected of having SFTS to the tertiary hospital, with possible consideration of nosocomial transmission of SFTS, pending the availability of the confirmatory test result.

This study has several limitations. First, although this study included endemic zoonoses in Korea other than scrub typhus or HFRS, such as leptospirosis, Q fever, or HGA, no patient with these diseases met the enrollment criteria. We included 6 HFRS patients diagnosed with a single high titer. However, incorrect diagnosis was not probable as these patients not only had positive serologic results but also had clinical manifestations and an exposure history relevant to HFRS. Second, there have been recent reports of co-infection of SFTS with other zoonoses.[@B22][@B23] The patients with all three (SFTS, scrub typhus, and HFRS) test results were enrolled; thus, it is likely that co-infected cases occurred among those patients that were excluded from this study. We also excluded bacteremia from this study, but some types of bacteremia may be associated with endemic zoonoses. Although we excluded such co-infections to develop a clear predictive scoring system, further study is needed to determine how to distinguish co-infected cases from others. Third, the comparative group did not contain a homogenous population. However, clinicians need a prediction tool to differentiate severe disease among heterogenous populations, and the results of this study confirm the unique clinical findings of SFTS, which may be useful for primary care providers. Finally, we planned to re-evaluate for the likelihood of SFTS 2 days after admission in patients with low predictive scores at the time of admission. However, we could only apply the prediction score 2 days after admission in 27 patients; this was due to the lack of clinical information. Thus, we could not reach a conclusion from this study. Prospective validation study of this prediction score at the time of admission and a study to evaluate the usefulness of early reassessment for SFTS are warranted.

In summary, our study suggests a simple and useful scoring system to predict SFTS in patients suspected of having endemic zoonoses in Korea. We expect that this strategic approach would be helpful for primary care providers in early differentiation of SFTS from other endemic zoonoses and for improving the clinical outcomes in patients with SFTS.
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